Yunkang Group Limited (HK:2325) has released an update.
Yunkang Group Limited will hold an extraordinary general meeting on December 27, 2024, to approve a procurement framework agreement with Daan Gene Co., Ltd. The agreement outlines the purchase of reagents, consumables, and equipment for 2025-2027, with proposed annual caps totaling RMB156.63 million over three years. Shareholders are invited to vote on this significant transaction, which could impact the company’s future procurement strategy.
For further insights into HK:2325 stock, check out TipRanks’ Stock Analysis page.